Principles for interactions with biopharmaceutical companies: the development of guidelines for patient advocacy organizations in the field of rare diseases. [electronic resource]
- Orphanet journal of rare diseases 01 2018
- 18 p. digital
Publication Type: Journal Article
1750-1172
10.1186/s13023-018-0761-2 doi
Decision Making Humans Patient Advocacy Public Health Rare Diseases